News blog

IXICO

  • BY: Andrew Hore |
  • POSTED: 12/08/2019 |

Neuroscience-focused digital data analysis technology developer IXICO has signed two new biopharmaceutical client contracts worth a total of more than £1m.

An ongoing phase III study has been extended and this will add £900,000 to the contract value.

One study has been discontinued following an interim review of data. It will not affect revenue this year, but contracted revenues of £3.5m were expected up until 2025. 

© 2020 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds